Immuneering Corporation (IMRX) Operating margin 2020–2022
Immuneering Corporation (IMRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-16325.8%FY2022 · since FY2020: -739.0% → -16325.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -16325.8% | -14696.6 pp |
| FY2021 | -1629.2% | -890.2 pp |
| FY2020 | -739.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMRX financial trends
IMRX RevenueIMRX Net incomeIMRX Net marginIMRX Gross profitIMRX Gross marginIMRX Operating incomeIMRX Operating cash flowIMRX Free cash flowIMRX Capital expendituresIMRX Return on equityIMRX Stock buybacksIMRX Dividends paidIMRX Total assetsIMRX Total liabilitiesIMRX Shareholders’ equityIMRX overview →